Skip to main content
. 2020 Jun 29;15(6):e0235126. doi: 10.1371/journal.pone.0235126

Fig 2. Probability of recurrence-free survival and overall survival for patients with surgically resected non-small cell lung cancer with or without IPF.

Fig 2

(A) Recurrence-free survival was significantly lower in the LC with IPF group than in the LC without IPF (P<0.001). (B) Overall survival was significantly lower in the LC with IPF group than in the LC without IPF (P<0.001).